Dr. Reddy's Laboratories Ltd. (RDY)

35.24
0.35 1.00
NYSE : Health Technology
Prev Close 34.89
Open 34.98
Day Low/High 34.96 / 35.50
52 Wk Low/High 31.58 / 42.82
Volume 164.31K
Avg Volume 183.80K
Exchange NYSE
Shares Outstanding 166.06M
Market Cap 5.85B
EPS 1.60
P/E Ratio 21.27
Div & Yield 0.26 (0.82%)

Dr. Reddy's To Release Q2 FY11 Results On October 23, 2010; Earnings Call Slated For October 23, 5:00 PM IST / 7.30 AM EST

Dr. Reddy's Laboratories (NYSE: RDY) will announce results for the Second Quarter ended September 30, 2010 on Saturday, October 23 rd 2010 after the Board Meeting.

Dr. Reddy’s Laboratories Limited Announces Filing Of Annual Report On Form 20-F

Dr. Reddy’s Laboratories Limited (NYSE: RDY) today announced that its Annual Report on Form 20-F, containing its annual consolidated financial statements for the fiscal year ended 31 March, 2010 was filed with the ...

Top 10 Emerging Markets Stocks to Watch

Top 10 Emerging Markets Stocks to Watch

These stocks clocked significant gains over the past month, outperforming the S&P.

Dr Reddy’s Launches Darbepoetin Alfa In India Under The Brand Name ‘Cresp®’

Dr. Reddy’s Laboratories Ltd.

Dr. Reddy’s Q1 FY11 Financial Results

Dr. Reddy’s Laboratories Ltd.

Focus on the Banking Sector

Before week's end, financial reform legislation is likely to pass and earnings are due from three big institutions.

Dr. Reddy's To Release Q1 FY11 Results On July 22, 2010; Earnings Call Slated For July 22, 6.30 PM IST / 9.00 AM EST

Dr. Reddy's To Release Q1 FY11 Results On July 22, 2010; Earnings Call Slated For July 22, 6.30 PM IST / 9.00 AM EST

Dr. Reddy's Laboratories (NYSE:RDY) will announce results for the first Quarter ended June 30, 2010 on Thursday, July 22, 2010 after the Board Meeting.

Dr. Reddy’s Announces The Launch Of Anastrozole 1mg Tablets

Dr. Reddy’s Laboratories (NYSE:RDY) today announced that it has launched anastrozole tablets, (1mg) , a bioequivalent generic version of Arimidex® (anastrozole tablets) in the US market on 28 June 2010.

Dr. Reddy’s Provides Update On The Fexofenadine-pseudoephedrine 24 Hour Preliminary Injunction Hearing

Dr. Reddy’s Laboratories (NYSE: RDY) announced today that the U.

Emerging Market ADRs Beat U.S. Stocks

S&P 500 lost 1.4% during the last one week, while emerging market ADRs gained between 5%-18% during the same period.

Dr. Reddy’s Announces The Launch Of Tacrolimus Capsules, The Generic Version Of Prograf®

Dr. Reddy’s Laboratories (NYSE:RDY) today announced that it has launched tacrolimus capsules, (0.

Dr. Reddy’s FY10 Financial Results

Dr. Reddy’s Laboratories Ltd.

Dr. Reddy's To Release Q4 & Full Year FY10 Results On May 6, 2010; Earnings Call Slated For May 6, 6.30 PM IST / 9.00 AM EST

Dr. Reddy's Laboratories (NYSE:RDY) will announce results for the Fourth Quarter & Full Year ended March 31, 2010 on Thursday, May 6, 2010 after the Board Meeting.

Dr. Reddy’s Announces The Launch Of Amlodipine Benazepril In US Market

Dr. Reddy’s Laboratories (NYSE:RDY) announced today that it launched amlodipine benazepril capsules (2.

Dr. Reddy’s Board Of Directors Approves Bonus Debentures Issue

The Board of Directors of Dr. Reddy’s Laboratories Limited (NYSE: RDY) today approved a scheme for the issue of bonus debentures by restructuring the general reserves of the company.

Health Stock Short-Squeeze Opportunities

Health Stock Short-Squeeze Opportunities

These heavily shorted health-related stocks could surge higher on any positive catalyst.

Ratings Changes: EMC, Dr. Reddy's, Nidec

Ratings Changes: EMC, Dr. Reddy's, Nidec

TheStreet.com Ratings has upgraded EMC and Nidec, and downgraded Dr. Reddy's Laboratories.

Synta and GSK Part Ways Over Cancer Drug

Synta and GSK Part Ways Over Cancer Drug

The venture between Synta and GSK ends, while GSK cements another deal with Dr. Reddy's.

Friday's Asia ADR Recap

Friday's Asia ADR Recap

These stocks from India and China are making moves and news in the U.S

Tuesday's Asia ADR Recap

Tuesday's Asia ADR Recap

These stocks from China and India are making moves and news in the U.S.

Tuesday's Asia ADR Recap

Tuesday's Asia ADR Recap

These stocks from China and India are making moves and news in the U.S.

Friday's Asia ADR Recap: Perfect World

Friday's Asia ADR Recap: Perfect World

These stocks from China and India are making moves and news in the U.S.

Friday's Asia ADR Recap: PetroChina

Friday's Asia ADR Recap: PetroChina

These stocks from China and India are making moves and news in the U.S.

Friday's Asia ADR Recap: Infosys

Friday's Asia ADR Recap: Infosys

The stocks from China and India making moves and news in the U.S.

Thursday's Asia ADR Recap: Solarfun

Thursday's Asia ADR Recap: Solarfun

The stocks from China and India making moves and news in the U.S.

Tuesday's Asia ADR Recap: Dr. Reddy's

Tuesday's Asia ADR Recap: Dr. Reddy's

The stocks from China and India making moves and news in the U.S.

Wednesday's Asia ADR Recap

Wednesday's Asia ADR Recap

The stocks from China and India making moves and news in the U.S.

Thursday's Asia ADR Recap

Thursday's Asia ADR Recap

The stocks from China and India making moves and news in the U.S.

Tuesday's Asia ADR Recap

Tuesday's Asia ADR Recap

The stocks from China and India making moves and news in the U.S.

Asia Stocks: Demand Rises

Asia Stocks: Demand Rises

The stocks from China and India making moves and news.

TheStreet Quant Rating: B- (Buy)